2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide
2022.1.0 - CI Build
2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide
2022.1.0 - CI Build
2022 CDC Clinical Practice Guideline for Prescribing Opioids Implementation Guide, published by Centers for Disease Control and Prevention (CDC). This guide is not an authorized publication; it is the continuous build for version 2022.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/opioid-cds-r4/ and changes regularly. See the Directory of published versions
| Official URL: http://fhir.org/guides/cdc/opioid-cds/PlanDefinition/opioidcds-10-order-sign | Version: 2022.1.0 | |||
| Draft as of 2024-11-19 | Computable Name: PlanDefinition_Recommendation_10_Order_Sign | |||
| Other Identifiers: cdc-opioid-guidance (use: official, ) | ||||
Usage:Clinical Focus: Medication requested (situation), Clinical Focus: Chronic pain (finding), Clinical Focus: |
||||
Copyright/Legal: © CDC 2016+. |
||||
When prescribing opioids for subacute or chronic pain, clinicians should consider the benefits and risks of toxicology testing to assess for prescribed medications as well as other prescribed and nonprescribed controlled substances.
The 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain is intended to improve communication between clinicians and patients about the benefits and risks of pain treatments, including opioid therapy; improve the effectiveness and safety of pain treatment; mitigate pain; improve function and quality of life for patients with pain; and reduce risks associated with opioid pain therapy, including opioid use disorder, overdose, and death. The recommendations do not apply to pain related to sickle cell disease or cancer or to patients receiving palliative or end-of-life care.
| Id: | opioidcds-10-order-sign-crd | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Url: | Recommendation #10 - Urine Drug Testing (order-sign) | ||||||||||||
| Version: | 2022.1.0 | ||||||||||||
| Identifier: |
value: cdc-opioid-guidance |
||||||||||||
| Name: | PlanDefinition_Recommendation_10_Order_Sign | ||||||||||||
| Title: | Recommendation #10 - Urine Drug Testing (order-sign) | ||||||||||||
| Status: | draft | ||||||||||||
| Experimental: | true | ||||||||||||
| Type: |
system: http://terminology.hl7.org/CodeSystem/plan-definition-type code: eca-rule display: ECA Rule |
||||||||||||
| Date: | 2024-11-19 | ||||||||||||
| Publisher: | Centers for Disease Control and Prevention (CDC) | ||||||||||||
| Description: | When prescribing opioids for subacute or chronic pain, clinicians should consider the benefits and risks of toxicology testing to assess for prescribed medications as well as other prescribed and nonprescribed controlled substances. | ||||||||||||
| Logic Definitions: |
|
||||||||||||
| Knowledge Capability: | shareable computable executable publishable | ||||||||||||
| Use Context: |
|
||||||||||||
| Purpose: | The 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain is intended to improve communication between clinicians and patients about the benefits and risks of pain treatments, including opioid therapy; improve the effectiveness and safety of pain treatment; mitigate pain; improve function and quality of life for patients with pain; and reduce risks associated with opioid pain therapy, including opioid use disorder, overdose, and death. The recommendations do not apply to pain related to sickle cell disease or cancer or to patients receiving palliative or end-of-life care. |
||||||||||||
| Usage: | Before starting opioids and periodically (at least annually) during opioid therapy, clinicians should consider the benefits and risks of toxicology testing to assess for prescribed opioids and other prescription and nonprescription controlled substances that increase risk for overdose when combined with opioids, including nonprescribed and illicit opioids and benzodiazepines. | ||||||||||||
| Copyright: | © CDC 2016+. |
||||||||||||
| Related Artifacts: |
Documentation |
||||||||||||
| Libraries: |
|
||||||||||||
| Actions: |
|